Bruno Lucidi

Insider Reports History

Location
Boston, MA
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Bruno Lucidi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bruno Lucidi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Atea Pharmaceuticals, Inc. Director Common Stock 112,750 $332,612 $2.95 20 Jun 2025 Direct
Atea Pharmaceuticals, Inc. Director Restricted Stock Units 0 $103,162 $3.49 20 Jun 2025 Direct
Atea Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 41,200 20 Jun 2025 Direct

Insider Reports Filed by Bruno Lucidi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVIR Atea Pharmaceuticals, Inc. 20 Jun 2025 4 $0 4 Director 24 Jun 2025, 18:05
AVIR Atea Pharmaceuticals, Inc. 21 Jun 2024 2 $0 4 Director 21 Jun 2024, 18:00
AVIR Atea Pharmaceuticals, Inc. 16 Jun 2024 2 $0 4 Director 18 Jun 2024, 17:00
AVIR Atea Pharmaceuticals, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 16:05
AVIR Atea Pharmaceuticals, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 19:45
AVIR Atea Pharmaceuticals, Inc. 18 Jun 2021 1 $0 4 Director 21 Jun 2021, 17:36